Forefront-Analytics

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
72
Total Value
86928433
Accession Number
0001085146-25-003053
Form Type
13F-HR
Manager Name
Forefront-Analytics
Data Enrichment
76% identified
55 identified17 unidentified

Holdings

72 positions • $86.9M total value
Manager:
Search and click to pin securities to the top
Page 3 of 3
Immatics N.V.
Shares:16.0K
Value:$71.8K
% of Portfolio:0.1% ($71.8K/$86.9M)
iTeos Therapeutics, Inc.
Shares:11.1K
Value:$66.4K
% of Portfolio:0.1% ($66.4K/$86.9M)
CytomX Therapeutics, Inc.
Shares:100.1K
Value:$63.1K
% of Portfolio:0.1% ($63.1K/$86.9M)
Annexon, Inc.
Shares:28.6K
Value:$55.3K
% of Portfolio:0.1% ($55.3K/$86.9M)
Nkarta, Inc.
Shares:29.2K
Value:$54.1K
% of Portfolio:0.1% ($54.1K/$86.9M)